A 32-week, Monocentric, Exploratory, Single Arm Study to Assess Immune Function and MRI Disease Activity in Patients with Relapsing Remitting Multiple Sclerosis (RRMS) Transferred from Previous Treatment with Natalizumab to Gilenya® (Fingolimod) (ToFingo-Successor)
Basic data for this project
Type of project: Own resources project
Duration at the University of Münster: 01/01/2014 - 30/06/2016
Description
Keywords: Multiple Sclerosis
Project management at the University of Münster
| Faldum, Andreas | Center of Clinical Trials (ZKS) |
Research associates from the University of Münster
| Eveslage, Maria | Institute of Biostatistics and Clinical Research (IBKF) |
| Urban, Marc | Center of Clinical Trials (ZKS) |